CoChat

Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

Open access
Alliance of Liver Cancer Conversion Therapy, Committee of Liver Cancer of the Chinese Anti-Cancer Association, Sun, Hui-Chuan, Zhou, Jian, Wang, Zheng, Liu, Xiufeng, Xie, Qing, Jia, Weidong, Zhao, Ming, Bi, Xinyu, Li, Gong, Bai, Xueli, Ji, Yuan, Xu, Li, Zhu, Xiao-Dong, Bai, Dousheng, Chen, Yajin, Chen, Yongjun, Dai, Chaoliu, Guo, Rongping, Guo, Wenzhi, Hao, Chunyi, Huang, Tao, Huang, Zhiyong, Li, Deyu, Li, Gang, Li, Tao, Li, Xiangcheng, Li, Guangming, Liang, Xiao, Liu, Jingfeng, Liu, Fubao, Lu, Shichun, Lu, Zheng, Lv, Weifu, Mao, Yilei, Shao, Guoliang, Shi, Yinghong, Song, Tianqiang, Tan, Guang, Tang, Yunqiang, Tao, Kaishan, Wan, Chidan, Wang, Guangyi, Wang, Lu, Wang, Shunxiang, Wen, Tianfu, Xing, Baocai, Xiang, Bangde, Yan, Sheng, Yang, Dinghua, Yin, Guowen, Yin, Tao, Yin, Zhenyu, Yu, Zhengping, Zhang, Bixiang, Zhang, Jialin, Zhang, Shuijun, Zhang, Ti, Zhang, Yamin, Zhang, Yubao, Zhang, Aibin, Zhao, Haitao, Zhou, Ledu, Zhang, Wu, Zhu, Zhenyu, Qin, Shukui, Shen, Feng, Cai, Xiujun, Teng, Gaojun, Cai, Jianqiang, Chen, Minshan, Li, Qiang, Liu, Lianxin, Wang, Weilin, Liang, Tingbo, Dong, Jiahong, Chen, Xiaoping, Wang, Xuehao, Zheng, Shusen, Fan, Jia · 2022 · Hepatobiliary Surgery and Nutrition
Cited by 206

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Recent advances in systemic and locoregional treatments for patients with unresectable or advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This has provided an opportunity for selected patients with initially unresectable HCC to achieve adequate tumor downstaging to undergo surgical resection, a 'conversion therapy' strategy. However, conversion therapy is a new approach to the treatment of HCC and its practice and treatment protocols are still being developed. Review the evidence for conversion therapy in HCC and develop consensus statements to guide clinical practice. Evidence review: Many research centers in China have accumulated significant experience implementing HCC conversion therapy. Preliminary findings and data have shown that conversion therapy represents an important strategy to maximize the survival of selected patients with intermediate stage to advanced HCC; however, there are still many urgent clinical and scientific challenges for this therapeutic strategy and its related fields. In order to summarize and learn from past experience and review current challenges, the Chinese Expert Consensus on Conversion Therapy for Hepatocellular Carcinoma (2021 Edition) was developed based on a review of preliminary experience and clinical data from Chinese and non-Chinese studies in this field and combined with recommendations for clinical practice. Sixteen consensus statements on the implementation of conversion therapy for HCC were developed. The statements generated in this review are based on a review of clinical evidence and real clinical experience and will help guide future progress in conversion therapy for patients with HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21037/hbsn-21-328

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 206

Metadata

Authors
Alliance of Liver Cancer Conversion Therapy, C. O. L. C. O. T. C. A.-C. A., Sun, H.-C., Zhou, J., Wang, Z., Liu, X., Xie, Q., Jia, W., Zhao, M., Bi, X., Li, G., Bai, X., Ji, Y., Xu, L., Zhu, X.-D., Bai, D., Chen, Y., Chen, Y., Dai, C., Guo, R., Guo, W., Hao, C., Huang, T., Huang, Z., Li, D., Li, G., Li, T., Li, X., Li, G., Liang, X., Liu, J., Liu, F., Lu, S., Lu, Z., Lv, W., Mao, Y., Shao, G., Shi, Y., Song, T., Tan, G., Tang, Y., Tao, K., Wan, C., Wang, G., Wang, L., Wang, S., Wen, T., Xing, B., Xiang, B., Yan, S., Yang, D., Yin, G., Yin, T., Yin, Z., Yu, Z., Zhang, B., Zhang, J., Zhang, S., Zhang, T., Zhang, Y., Zhang, Y., Zhang, A., Zhao, H., Zhou, L., Zhang, W., Zhu, Z., Qin, S., Shen, F., Cai, X., Teng, G., Cai, J., Chen, M., Li, Q., Liu, L., Wang, W., Liang, T., Dong, J., Chen, X., Wang, X., Zheng, S., & Fan, J.
Venue
Hepatobiliary Surgery and Nutrition
Published
2022-04
Volume
11
Issue
2
Pages
227-252
ISSN
  • 2304-3881 (ISSN-L)
  • 2304-389X
OpenAlex
W4211183255
Cited by
206
References
7
FWCI
23.26
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition). https://app.cochat.ai/papers/10.21037/hbsn-21-328
The paper
Alliance of Liver Cancer Conversion Therapy, C. O. L. C. O. T. C. A.-C. A., Sun, H.-C., Zhou, J., Wang, Z., Liu, X., Xie, Q., Jia, W., Zhao, M., Bi, X., Li, G., Bai, X., Ji, Y., Xu, L., Zhu, X.-D., Bai, D., Chen, Y., Chen, Y., Dai, C., Guo, R., . . . Fan, J. (2022). Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition). Hepatobiliary Surgery and Nutrition. https://doi.org/10.21037/hbsn-21-328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.